Abbott India Limited

BSE: 500488 NSE: ABBOTINDIA
Abbott India Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24239MH1944PLC007330 Incorporated 22 August 1944 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: ABBOTINDIA · BSE: 500488 Public Limited Company pharma
Data last updated
Market Cap
₹57,078 Cr
ABBOTINDIA · NSE
Share Price
₹26,955.00
+0.35% today
Revenue
₹6,960 Cr
FY 2025-26 · +6.7% YoY
EBITDA
₹1,892 Cr
Margin 27.2%
Net Profit
₹1,547 Cr
FY 2025-26 · +9.3% YoY
P/E (TTM)
56.6x
P/B 17.5x
ROE
34.5%
ROCE 43.8%
Debt / Equity
0.04
Interest cover 1.4x

About Abbott India Limited

Data last updated: 26 September 2026

Abbott India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Abbott Capital India Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 22 August 1944, the company has been in operation for over 82 years.

Registered with ROC Mumbai under CIN L24239MH1944PLC007330. Listed on BSE: 500488 and NSE: ABBOTINDIA.

Capital: an authorised share capital of ₹27.5 Cr and a paid-up capital of ₹21.25 Cr. Formerly known as Boots Pure Drug Company (India) Private Limited. It is led by directors including Kaiyomarz Minoo Marfatia and Munir Shaikh.

Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Unit No. 3 Corporate Park Sion Trombay Road Chembur, Mumbai, Maharashtra, India – 400071.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹6,960.49 Cr, a growth of 7.99% compared to the previous year. The net worth stands at ₹4,774.19 Cr (up 12.78% YoY). Total assets are valued at ₹5,063.69 Cr (up 11.31% YoY).

The company has a workforce of approximately 3,924 employees as per the latest available data. It operates as a subsidiary of Abbott Capital India Limited.

The company is associated with 2 brands - Cremaffin, Abbott.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abbott.co.in.

Company Details of Abbott India Limited
CIN L24239MH1944PLC007330
Registration Number 007330
Incorporation Date 22 August 1944
ROC Mumbai
Listing Status Listed (BSE: 500488, NSE: ABBOTINDIA)
Company Status Active
Date of Last AGM 13 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Abbott Capital India Limited
Compliance Status Active Compliant
Key People
Kartik Rajendran Managing Director Maithilee Kaizad Mistry Cfo Kaiyomarz Minoo Marfatia Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    abbott.co.in
  • Social Media
  • Registered Address
    Unit No. 3 Corporate Park Sion Trombay Road Chembur, Mumbai, Maharashtra, India – 400071
  • Industry
    Pharma, Drug Formulation & Development
Company report
Abbott India Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Abbott India Limited report

Financials, compliance, directors, charges, ownership and filings for Abbott India Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Abbott India Limited

Abbott India Limited has one previous CIN (Corporate Identification Number): L24239MH1949PLC007330. The current CIN is L24239MH1944PLC007330, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24239MH1944PLC007330 Current
L24239MH1949PLC007330 Previous

Associated Brands with Abbott India Limited

Abbott India Limited operates two associated brands: Cremaffin and Abbott. These brands represent Abbott India Limited's diversified market presence and brand portfolio.

Brand Description Website
Abbott
Developer of medical devices, generic pharmaceuticals, and nutrition products abbott.com
Cremaffin
Provision of constipation relief products and services is handled by Cremaffin. cremaffin.com

Business Activity of Abbott India Limited

Abbott India Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Abbott India Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Abbott India Limited

Abbott India Limited is audited by Walker Chandiok & Co LLP for the financial year 2025. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Walker Chandiok & Co LLP Locked Locked Locked
Premium access

Complete auditor history for Abbott India Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Abbott India Limited

Abbott India Limited currently reports 9 directors and 1 key managerial person. 32 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Kaiyomarz Minoo Marfatia
Also directs: Snl Bearings Limited
Director 01 Mar 2011 15 Years 6 Months Current
Munir Shaikh Director 02 Mar 2001 25 Years 6 Months Current
Anisha Motwani
Also directs: Motherson Sumi Wiring India Limited, Ceigall India Limited, Star Health And Allied Insurance Company Limited and 5 more
Director 25 Apr 2018 8 Years 5 Months Current
Sudarshan Jain Director 01 Apr 2019 7 Years 5 Months Current
Shalini Kalsi Kamath
Also directs: Bosch Home Comfort India Limited, Expleo Solutions Limited, Healthium Medtech Limited and 3 more
Director 29 Oct 2019 6 Years 10 Months Current
Vivek Mohan Director 01 Jan 2026 0 Years 8 Months Current
Showing 6 of 10 current directors and KMP. View all directors and KMP

Financials of Abbott India Limited FY 2025-26 filings available

Abbott India Limited reported revenue of ₹6,960.49 Cr (up 7.99% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹6,960 Cr
+8.0% YoY
EBITDA
₹1,892 Cr
+11.7% YoY
Profit After Tax
₹1,547 Cr
+9.3% YoY
Net Worth
₹4,774 Cr
+12.8% YoY
Total Assets
₹5,064 Cr
+11.3% YoY
Total Debt
₹172 Cr
-12.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue6,9606,4465,8755,3794,9194,3104,093
Revenue growth+6.7%+7.4%+6.0%+8.9%+13.1%+1.6%+8.6%
EBITDA1,8921,6951,4531,2061,088921756
EBITDA margin+27.2%+26.3%+24.7%+22.4%+22.1%+21.4%+18.5%
Profit before tax2,0791,8871,6181,2741,080926803
Net profit1,5471,4151,201950799691593
Net profit margin+22.2%+22.0%+20.4%+17.7%+16.2%+16.0%+14.5%
EPS (₹)730.36665.62565.28446.78375.86325.03279.03
Balance sheet
Total assets5,0644,5493,8973,3953,0642,8442,691
Net worth4,7744,2333,6993,1892,8202,6022,432
Total debt17219783.23113152153175
Cash & bank2,2551,6262,1341,9372,7492,4092,197
Net working capital2,3323,3951,9501,8652,6932,4912,349
Cash flow
Cash from operations1,3191,0121,213893948727626
Cash from investing(371)182(416)(148)(396)(71.82)(401)
Cash from financing(1,066)(925)(745)(639)(637)(582)(217)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,8141,7101,7241,7571,7381,6051,6141,633
Revenue growth (YoY)+4.3%+6.5%+6.8%+7.6%+11.6%+11.5%+12.3%+9.3%
Other income75.3775.5969.7669.9572.8476.0271.7560.48
Total expenses1,2911,2291,2611,2551,2931,1761,1781,194
EBITDA522481463502446429436439
EBITDA margin+28.8%+28.1%+26.9%+28.6%+25.6%+26.7%+27.0%+26.9%
Depreciation19.7519.0718.7718.6419.4817.9317.9917.51
Interest5.916.145.487.555.823.922.262.50
Profit before tax572531509546493483488479
Tax144136133131127116127121

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 26 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,8141,7101,7241,7571,7381,6051,6141,633
Revenue growth (YoY)+4.3%+6.5%+6.8%+7.6%+11.6%+11.5%+12.3%+9.3%
Other income75.3775.5969.7669.9572.8476.0271.7560.48
Total expenses1,2911,2291,2611,2551,2931,1761,1781,194
EBITDA522481463502446429436439
EBITDA margin+28.8%+28.1%+26.9%+28.6%+25.6%+26.7%+27.0%+26.9%
Depreciation19.7519.0718.7718.6419.4817.9317.9917.51
Interest5.916.145.487.555.823.922.262.50
Profit before tax572531509546493483488479
Tax144136133131127116127121
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue6,9606,4465,8755,3794,9194,3104,093
Revenue growth+6.7%+7.4%+6.0%+8.9%+13.1%+1.6%+8.6%
Other income28827624815477.2180.90114
Total expenses5,0684,7514,4224,1733,8323,3893,337
Employee cost669588577564579493476
EBITDA1,8921,6951,4531,2061,088921756
EBITDA margin+27.2%+26.3%+24.7%+22.4%+22.1%+21.4%+18.5%
Depreciation75.9671.8071.1769.9766.1058.1359.61
Interest24.9911.4312.4515.9919.1018.288.53
Profit before tax2,0791,8871,6181,2741,080926803
Tax527473417324281235210
Net profit1,5471,4151,201950799691593
Net profit margin+22.2%+22.0%+20.4%+17.7%+16.2%+16.0%+14.5%
EPS (₹)730.36665.62565.28446.78375.86325.03279.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital21.2521.2521.2521.2521.2521.2521.25
Reserves & surplus4,7534,2123,6783,1672,7992,5812,410
Shareholders' funds (net worth)4,7744,2333,6993,1892,8202,6022,432
Secured loans0.000.000.000.000.000.000.00
Unsecured loans17219783.23113152153175
Total debt17219783.23113152153175
Total liabilities5,0644,5493,8973,3953,0642,8442,691
Assets
Gross block567553424367382341345
Net block331336225237271251270
Capital work in progress5.5118.0810.113.660.660.661.64
Investments0.000.000.000.000.000.000.00
Inventories947882620649688718527
Sundry debtors362380319317288250318
Cash & bank balances2,2551,6262,1341,9372,7492,4092,197
Loans & advances2071,875173122128111162
Total current assets3,7714,7633,2463,0253,8533,4873,205
Total current liabilities1,4381,3681,2961,1601,160996855
Net working capital2,3323,3951,9501,8652,6932,4912,349
Total assets5,0644,5493,8973,3953,0642,8442,691
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash561292240133218145137
Net cash from operating activities1,3191,0121,213893948727626
Net cash from investing activities(371)182(416)(148)(396)(71.82)(401)
Net cash from financing activities(1,066)(925)(745)(639)(637)(582)(217)
Net change in cash(118)26952.07107(85.56)73.138.13
Closing cash2,2551,6262,1341,9372,7492,4092,197
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+8.0%+9.7%+9.2%+9.4%+14.1%+5.3%+11.3%
EBITDA growth+11.7%+16.6%+20.5%+10.8%+18.0%+21.8%+25.1%
PBT growth+10.2%+16.6%+27.0%+18.0%+16.6%+15.4%+14.9%
Net income growth+9.3%+17.8%+26.5%+18.9%+15.6%+16.4%+33.6%
Revenue CAGR (3Y)+9.0%+9.4%+10.9%+9.5%+10.2%+9.3%+12.1%
EBITDA CAGR (3Y)+16.2%+15.9%+16.4%+16.8%+21.6%+20.7%+23.9%
Profitability & leverage
Net income margin+22.3%+21.9%+20.5%+17.7%+16.2%+16.0%+14.5%
Return on capital employed+43.8%+45.0%+44.7%+39.9%+37.2%+34.1%+34.0%
Return on net worth+34.5%+35.7%+34.9%+31.6%+29.5%+27.4%+26.7%
Debt / equity0.040.040.030.040.060.070.04
Long-term debt / equity0.030.020.020.030.040.050.03
Interest cover1.380.700.901.411.872.121.22
Efficiency & per share
Fixed asset turnover12.4313.1914.8514.3713.6212.5816.08
Inventory turnover7.618.599.268.057.006.937.22
Debtors turnover18.7618.4318.4717.7818.2715.1713.78
EPS (₹)730.36665.62565.28446.78375.86325.03279.03
Dividend per share (₹)656.00475.00410.00325.00275.00275.00250.00
Book value per share (₹)2,246.681,992.071,740.651,500.491,326.961,224.551,144.33
Want more history and ratios?
You're viewing the latest exchange-filed financials for Abbott India Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Abbott India Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 75.00%, foreign institutional investors hold 0.40%, domestic institutional investors hold 8.80%, retail and other public shareholders hold 15.80% of Abbott India Limited.

Promoters: 75.00%DII (Domestic Institutional): 8.80%FII (Foreign Institutional): 0.40%Retail & Others: 15.80%
Jun 2026
QUARTER
75.00% Promoters
8.80% DII (Domestic Institutional)
0.40% FII (Foreign Institutional)
15.80% Retail & Others
Promoter holding - history
Now 75.00% · Jun 2026High 75.00% · Sep 2025Low 75.00% · Sep 2025
74%74.5%75%75.5%76%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 75.00%Dec 2025: 75.00%Mar 2026: 75.00%Jun 2026: 75.00%75.00%75.00%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters75.00%75.00%75.00%75.00%
Public25.00%25.00%25.00%25.00%

Charges & Borrowings Abbott India Limited

Abbott India Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Abbott India Limited

Abbott India Limited has a workforce of 3,924 employees as of Sep 24, 2025.

Employee count
3,924
Active EPFO establishments
7
Employee growth
-3.47%
Premium access

Employee and EPFO history for Abbott India Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Abbott India Limited

Premium access

GST registrations and filing compliance for Abbott India Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Abbott India Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Abbott India Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Abbott India Limited

Premium access

MSME payment history for Abbott India Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Abbott India Limited

Premium access

Corporate group structure for Abbott India Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Abbott India Limited

Premium access

MCA filings and documents for Abbott India Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Abbott India Limited

Directors
01 Jan 2026
Vivek Mohan was appointed as a Director on 01 Jan 2026 & has been associated with this company since 8 months 26 days.
Directors
18 Aug 2025
Darshan Pravin Gada was appointed as a Director on 18 Aug 2025 & has been associated with this company since 1 year 1 month.
Activity
13 Aug 2025
Abbott India Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records.
Directors
14 Jun 2025
Kartik Rajendran was appointed as a Managing Director on 14 Jun 2025 & has been associated with this company since 1 year 3 months.
Directors
29 May 2025
Maithilee Kaizad Mistry was appointed as a CFO on 29 May 2025 & has been associated with this company since 1 year 4 months.
Activity
31 Mar 2025
Abbott India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.

Recent News on Abbott India Limited

Shyamakant Giri is new CEO of Gland Pharma
18 Oct 2024 · Thehindubusinessline

Frequently Asked Questions about Abbott India Limited

Abbott India Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 22 August 1944 (82+ years old) and is registered under CIN L24239MH1944PLC007330. Listed on BSE: 500488 and NSE: ABBOTINDIA. The company has 3,924 employees.

Abbott India Limited reported revenue of ₹6,960.49 Cr for FY 2025-26 (up 7.99% YoY) based on standalone financials.

The current directors and KMP of Abbott India Limited are:

The primary industry of Abbott India Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Abbott India Limited is listed on both BSE (code: 500488) and NSE (symbol: ABBOTINDIA).

Abbott India Limited can be reached at the registered office: Unit No. 3 Corporate Park Sion Trombay Road Chembur, Mumbai, Maharashtra, India – 400071, or through the website abbott.co.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available